IP Library › Granted Patent US 10,047,242
Granted Patent B2
US 10,047,242 · App. 14/784,972 · Granted Aug 14, 2018

Bondable blood-friendly polymer and preparing method thereof

Inventors: Sicong Lin (Nanjing, CN); Hui Lin (Nanjing, CN); Wei Wu (Nanjing, CN)
Assignee: GY BIO-MATERIALS CO., LTD.
C09D133/14C08F220/28C08F226/02C08F290/062C09D143/02C09J133/14
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,047,242
App. No.
14/784,972
Granted
Aug 14, 2018
Kind
B2
Abstract

A bondable blood-friendly polymer is a terpolymer or a quadripolymer at least formed by polyethylene glycol alkyl ether acrylate or polyethylene glycol alkyl ether methacrylate (I), and zwitterionic acrylic ester or zwitterionic methacrylic ester (II), and acrylic acid or a methacrylate derivative with an epoxypropyl group, an isocyanate group, a trialkoxy silane, a hydroxyalkyl group, a propargyl group or a quaternary ammonium group (III). In the present invention, the blood-friendly polymer with a potentially-bondable group has the following advantages: although the water insolubility thereof is implemented by using the hydrophobicity physical effect of an existing higher alkyl acrylate linkage, the blood friendliness of a coating is reduced due to the existence of a great number of hydrophobic chain links in the polymer; and a physical coating is slowly desolventized from the surface to be ablated in the application process of the physical coating. A disclosed bondable blood-friendly polymer coating not only can overcome these defects, but also can improve the blending property thereof. Disclosed are composition, a structure and a preparation method of the bondable blood-friendly polymer.

Claims (53)

1. A bondable blood-friendly polymer polymerized by at least three kinds of monomers; the three kinds of monomers are:

a first monomer (I), which is a polyethylene glycol alkyl ether acrylate or a polyethylene glycol alkyl ether methacrylate;

a second monomer (II), which is a zwitterionic acrylic ester or a zwitterionic methacrylic ester; and

a third monomer (III), which has a chemical structure selected from

wherein n=2, 3, or 4;

wherein a mole ratio of the first monomer (I), the second monomer (II) and the third monomer (III) is 1-9:1-7:0.2-3.

2. The bondable blood-friendly polymer of claim 1 , wherein the first monomer (I) has a chemical structure below:

wherein R 1 is H, or CH 3 ;

R 2 is CH 3 ; and

n is 2-114.

3. The bondable blood-friendly polymer of claim 1 , wherein the second monomer (II) has a chemical structure selected from

wherein R 1 is H or CH 3 , and R 2 is CH 3 or C 2 H 5 ;

wherein R 1 is H or CH 3 , R 2 is CH 3 or C 2 H 5 , and R 3 is C 6 -C 12 ;

wherein R is CH 3 or C 2 H 5 ; and

wherein R 1 is H or CH 3 , and R 2 is CH 3 or C 2 H 5 .

4. The bondable blood-friendly polymer of claim 1 , wherein the polymer is polymerized by four kinds of monomers, the four kinds of monomers are the first monomer (I), the second monomer (II), the third monomer (III) and a fourth monomer (IV) which is a higher alkyl methacrylate or a 3-[tris (trimethylsiloxy) silyl]propyl methacrylate.

5. The bondable blood-friendly polymer of claim 4 , wherein a mole ratio of the first monomer (I), the second monomer (II), the third monomer (III) and the fourth monomer (IV) is 1-8:1-7:0.2-3:2-4.

6. A coating layer on a manufacture, wherein a material of the coating layer comprises a polymer polymerized by monomers comprising:

a first monomer (I), which is a polyethylene glycol alkyl ether acrylate or a polyethylene glycol alkyl ether methacrylate;

a second monomer (II), which is a zwitterionic acrylic ester or a zwitterionic methacrylic ester; and

a third monomer (III), which has a chemical structure selected from

wherein n=2, 3, or 4;

wherein a mole ratio of the first monomer (I), the second monomer (II) and the third monomer (III) is 1-9:1-7:0.2-3.

7. The coating layer of claim 6 , wherein the first monomer (I) has a chemical structure below:

wherein R 1 is H, or CH 3 ;

R 2 is CH 3 ; and

n is 2-114.

8. The coating layer of claim 6 , wherein the second monomer (II) has a chemical structure selected from

wherein R 1 is H or CH 3 , and R 2 is CH 3 or C 2 H 5 ;

wherein R 1 is H or CH 3 , R 2 is CH 3 or C 2 H 5 , and R 3 is C 6 -C 12 ;

wherein R is CH 3 or C 2 H 5 ; and

wherein R 1 is H or CH 3 , and R 2 is CH 3 or C 2 H 5 .

9. The coating layer of claim 6 , wherein the monomers further comprises a fourth monomer (IV), which is a higher alkyl methacrylate or a 3-[tris (trimethylsiloxy) silyl]propyl methacrylate.

10. The coating layer of claim 9 , wherein a mole ratio of the first monomer (I), the second monomer (II), the third monomer (III) and the fourth monomer (IV) is 1-8:1-7:0.2-3:2-4.

11. The coating layer of claim 6 , wherein the coating layer is coated on a manufacture made from a material of a glass, a ceramics, or a metal.

12. A method of preparing bondable blood-friendly polymer, the method comprising:

adding a first monomer (I), a second monomer (II), a third monomer (III), and a radical initiator into a solvent, wherein the first monomer (I) is a polyethylene glycol alkyl ether acrylate or a polyethylene glycol alkyl ether methacrylate, the second monomer (II) is a zwitterionic acrylic ester or a zwitterionic methacrylic ester, the third monomer (III) has a chemical structure selected from

wherein n=2, 3, or 4;

the solvent is an alcohol, a mixed solvent of alcohol and tetrahydrofuran, or dimethyl sulfoxide; and the radical initiator is azobisisobutyronitrile (AIBN), azobiscyanovaleric acid (ACVA), or benzoyl peroxide (BPO);

polymerizing the first monomer (I), the second monomer (II), and the third monomer (III) under nitrogen atmosphere at 60-70° C. for 24-45 h to obtain a polymer;

and precipitating the polymer in an anhydrous ether.

13. The method of claim 12 , wherein a mole ratio of the first monomer (I), the second monomer (II) and the third monomer (III) is 1-9:1-7:0.2-3.

14. The method of claim 12 , further comprising adding a fourth monomer (IV) into the solvent to be polymerized with the first monomer (I), the second monomer (II), and the third monomer (III), wherein the fourth monomer (IV) is a higher alkyl methacrylate or a 3-[tris (trimethylsiloxy) silyl]propyl methacrylate.

15. The method of claim 14 , wherein a mole ratio of the first monomer (I), the second monomer (II), the third monomer (III) and the fourth monomer (IV) is 1-8:1-7:0.2-3:2-4.

16. The method of claim 12 , wherein the first monomer (I) has a chemical structure below:

wherein R 1 is H, or CH 3 ;

R 2 is CH 3 ; and

n is 2-114.

17. The method of claim 12 , wherein the second monomer (II) has a chemical structure selected from

wherein R 1 is H or CH 3 , and R 2 is CH 3 or C 2 H 5 ;

wherein R 1 is H or CH 3 , R 2 is CH 3 or C 2 H 5 , and R 3 is C 6 -C 12 ;

wherein R is CH 3 or C 2 H 5 ; and

wherein R 1 is H or CH 3 , and R 2 is CH 3 or C 2 H 5 .

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 20, 2025
From: ANQING GOUYOU BIOMATERIALS TECHNOLOGY CO., LTD.
To: SHANGHAI OLI ENTERPRISES CO., LTD.
Reel/Frame 072073/0267 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 24, 2020
From: G.Y. BIOMATERIALS CO., LTD.
To: ANQING GOUYOU BIOMATERIALS TECHNOLOGY CO., LTD.
Reel/Frame 052200/0482 →
Priority Claims (1)
CN 2013 1 0153549 · Apr 27, 2013 · national
Continuity (1)
Related Publication 20160083610A1 · Mar 24, 2016